Lexicon Pharmaceuticals Inc Strategic Asset Allocation Index
Lexicon Pharmaceuticals Inc strategic asset allocation index. Lexicon Pharmaceuticals Inc (LXRX) has a Strategic Asset Allocation Index of 1.2% as of June 2023. Strategic assets (PP&E of $2.20 Million plus long-term investments of $-) total $2.20 Million, measured against net assets of $186.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Lexicon Pharmaceuticals Inc (LXRX) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lexicon Pharmaceuticals Inc (2000–2022)
Strategic asset allocation index of Lexicon Pharmaceuticals Inc from 2000 to 2022. This chart shows how Lexicon Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of June 2023, the index stands at 1.2%, representing strategic assets of $2.20 Million against net assets of $186.36 Million USD. Check Lexicon Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Lexicon Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2022)
Lexicon Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Lexicon Pharmaceuticals Inc from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Lexicon Pharmaceuticals Inc (LXRX) total market value.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.8% | $2.07 Million | $2.07 Million | $- | $117.12 Million | ▲ +0.7 pp |
| 2021 | 1.0% | $1.18 Million | $1.18 Million | $- | $113.59 Million | ▲ +0.8 pp |
| 2020 | 0.2% | $295.00K | $295.00K | $- | $156.37 Million | ▼ -11.8 pp |
| 2019 | 12.0% | $14.05 Million | $14.05 Million | $- | $117.10 Million | ▼ -22.0 pp |
| 2017 | 33.9% | $17.69 Million | $17.69 Million | $- | $52.10 Million | ▲ +21.6 pp |
| 2016 | 12.3% | $19.39 Million | $19.39 Million | $- | $157.40 Million | ▲ +4.9 pp |
| 2015 | 7.4% | $21.23 Million | $21.23 Million | $- | $285.85 Million | ▲ +7.0 pp |
| 2014 | 0.4% | $1.08 Million | $1.08 Million | $- | $284.02 Million | ▼ -23.9 pp |
| 2013 | 24.3% | $41.36 Million | $41.36 Million | $- | $170.16 Million | ▲ +8.3 pp |
| 2012 | 16.0% | $42.63 Million | $42.63 Million | $- | $266.68 Million | ▲ +0.4 pp |
| 2011 | 15.6% | $46.42 Million | $46.42 Million | $- | $297.57 Million | ▼ -6.0 pp |
| 2010 | 21.6% | $53.43 Million | $53.43 Million | $- | $247.02 Million | ▼ -14.3 pp |
| 2009 | 35.9% | $58.75 Million | $58.75 Million | $- | $163.50 Million | ▲ +2.7 pp |
| 2008 | 33.2% | $65.09 Million | $65.09 Million | $- | $195.83 Million | ▲ +8.5 pp |
| 2007 | 24.7% | $70.83 Million | $70.83 Million | $- | $286.57 Million | ▼ -66.7 pp |
| 2006 | 91.5% | $78.19 Million | $78.19 Million | $- | $85.50 Million | ▼ -7.9 pp |
| 2005 | 99.4% | $85.27 Million | $85.27 Million | $- | $85.80 Million | ▲ +29.8 pp |
| 2004 | 69.6% | $84.57 Million | $84.57 Million | $- | $121.59 Million | ▲ +19.2 pp |
| 2003 | 50.3% | $83.68 Million | $83.68 Million | $- | $166.22 Million | ▲ +28.4 pp |
| 2002 | 22.0% | $37.36 Million | $37.36 Million | $- | $169.90 Million | ▲ +9.8 pp |
| 2001 | 12.2% | $26.71 Million | $26.71 Million | $- | $218.37 Million | ▲ +5.3 pp |
| 2000 | 7.0% | $14.48 Million | $14.48 Million | $- | $207.63 Million | — |